DSM and Cargill join forces to bring fermentation-based stevia to the market

November 09, 2018
Accelerating Materials Innovation More...
Partnership More...
Very important

DSM and Cargill recently announced a joint venture (JV), "Avansya," to commercialize next-generation stevia rebaudiosides Reb M and Reb D. As a part of this 50-50 JV, the companies hope to combine DSM's strain development expertise and Cargill's large-scale fermentation capacity to bring fermentation-based rebaudiosides to the market under the "EverSweet" brand. The exact details of this JV will be finalized by Q1 2019. Currently, it remains unclear how this JV will affect Cargill's previous licensing agreement with Evolva, but Cargill's commercialization timeline was significantly delayed due to problems with strain optimization. Clients should note that this JV is likely to expedite the launch of the fermentation-derived stevia product.

For the original news article, click here .

Further Reading

DMC partners with Conagen for commercial production of L-alanine

News Commentary | May 21, 2021

This announcement follows the company's recent effort to demonstrate the large‑scale production of L‑alanine through 85 m3 fermentation at EW Biotech in Germany. In April 2021, the company also struck a deal with SCG to bring L‑alanine and other branched‑chain amino acids to the ASEAN market. ... Not part of subscription


Company Profile | July 29, 2021

Offers an alternative way of producing chemicals through fermentation that it claims is more sustainable Differentiates through its capability to design the fermentation processes for scale‑up while steadily bringing down the cost Its first commercial product is 1,4‑butanediol (BDO), which it... Not part of subscription

Givaudan bets big on synthetic biology for specialty ingredients production

News Commentary | September 09, 2021

Givaudan and Manus Bio recently announced that they have achieved key scale‑up milestones in developing a food and beverage ingredient. While details on the target ingredient are scarce, Givaudan is looking to commercialize this ingredient by the end of this year. Interestingly, Givaudan also ... Not part of subscription